Evaluation of OCT biomarker changes in treatment-naive neovascular AMD using a deep semantic segmentation algorithm
View ORCID ProfileBen Asani, View ORCID ProfileOlle Holmberg, View ORCID ProfileJohannes B Schiefelbein, Michael Hafner, View ORCID ProfileTina Herold, View ORCID ProfileHannah Spitzer, View ORCID ProfileJakob Siedlecki, View ORCID ProfileChristoph Kern, View ORCID ProfileKarsten U. Kortuem, Amit Frishberg, View ORCID ProfileFabian J. Theis, View ORCID ProfileSiegfried G Priglinger
doi: https://doi.org/10.1101/2022.06.16.22276342
Ben Asani
2Department of Ophthalmology, Ludwig-Maximilians-University, Munich, Germany
Olle Holmberg
1Institute of Computational Biology, Helmholtz Zentrum München
Johannes B Schiefelbein
2Department of Ophthalmology, Ludwig-Maximilians-University, Munich, Germany
Michael Hafner
2Department of Ophthalmology, Ludwig-Maximilians-University, Munich, Germany
Tina Herold
2Department of Ophthalmology, Ludwig-Maximilians-University, Munich, Germany
Hannah Spitzer
1Institute of Computational Biology, Helmholtz Zentrum München
Jakob Siedlecki
2Department of Ophthalmology, Ludwig-Maximilians-University, Munich, Germany
Christoph Kern
2Department of Ophthalmology, Ludwig-Maximilians-University, Munich, Germany
Karsten U. Kortuem
4Department of Ophthalmology, Ulm University, Ulm, Germany
Amit Frishberg
1Institute of Computational Biology, Helmholtz Zentrum München
Fabian J. Theis
1Institute of Computational Biology, Helmholtz Zentrum München
3Department of Mathematics, TU Munich, Germany
Siegfried G Priglinger
2Department of Ophthalmology, Ludwig-Maximilians-University, Munich, Germany

Article usage
Posted June 17, 2022.
Evaluation of OCT biomarker changes in treatment-naive neovascular AMD using a deep semantic segmentation algorithm
Ben Asani, Olle Holmberg, Johannes B Schiefelbein, Michael Hafner, Tina Herold, Hannah Spitzer, Jakob Siedlecki, Christoph Kern, Karsten U. Kortuem, Amit Frishberg, Fabian J. Theis, Siegfried G Priglinger
medRxiv 2022.06.16.22276342; doi: https://doi.org/10.1101/2022.06.16.22276342
Evaluation of OCT biomarker changes in treatment-naive neovascular AMD using a deep semantic segmentation algorithm
Ben Asani, Olle Holmberg, Johannes B Schiefelbein, Michael Hafner, Tina Herold, Hannah Spitzer, Jakob Siedlecki, Christoph Kern, Karsten U. Kortuem, Amit Frishberg, Fabian J. Theis, Siegfried G Priglinger
medRxiv 2022.06.16.22276342; doi: https://doi.org/10.1101/2022.06.16.22276342
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)